JP Morgan Chase
TMDX icon

JP Morgan Chase’s Transmedics TMDX Stock Holding History

JP Morgan Chase’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,600
Closed -$1.19M – 7730
2024
Q3 		$1.19M Buy
+7,600
New +$1.17M ﹤0.01% 4358
2024
Q2 		– Sell
-30,000
Closed -$2.22M – 7744
2024
Q1 		$2.22M Buy
+30,000
New +$2.47M ﹤0.01% 3749

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

JP Morgan Chase's TMDX Position: Q2 2026 in Review

JP Morgan Chase reduced its Transmedics (TMDX) stake by 38% in Q2 2026, selling an estimated $9.83M and leaving 192,269 shares worth $13M. The position accounts for ﹤0.01% of the portfolio, ranked #2578.

JP Morgan Chase first reported a position in TMDX in Q2 2019 and has held it in 29 quarters since. The position peaked at $62.2M in Q2 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • JP Morgan Chase held 192,269 shares of Transmedics worth $13M as of Q2 2026.
  • JP Morgan Chase sold 116,072 Transmedics shares in Q2 2026, an estimated $9.83M.
  • Transmedics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2578 holding.
  • JP Morgan Chase first reported a position in Transmedics in Q2 2019 and has held it in 29 quarters since.
  • JP Morgan Chase's Transmedics position peaked at $62.2M in Q2 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.